Will Increase Covid Vaccination Sites Up To 5 Times, Says Centre

Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones.

Will Increase Covid Vaccination Sites Up To 5 Times, Says Centre

India has exported COVID-19 shots to 24 countries as part of a diplomatic push.

New Delhi:

India will increase the number of its COVID-19 vaccination sites by up to five times after administering nearly 9 million shots in a month, a government official said on Tuesday, amid concerns about the speed of coverage in the country.

Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones.

However it is vaccinating around 300,000 front-line workers a day, a total that will have to increase sharply to meet the government's target of covering 300 million of its 1.35 billion people by August, experts say.

The ongoing vaccination of front-line workers such as nurses and doctors has taught India how to scale up the campaign, Vinod Kumar Paul, who heads a government panel on vaccine strategy, told a news conference. "This learning will be of great use," he said, hours after taking the second dose of a government-backed vaccine.

"We are currently running 10,000-11,000 immunisation sessions. We will do four to five times of that when we start the next phase; wait for the pace to pick up."

India will begin immunising the public from next month, starting with those over 50 or with medical conditions. The country has covered 60 per cent of its nearly 10 million healthcare workers since starting the drive on January 16, though as many as 11 of the 36 states have not even reached the halfway mark.

"These are not very unsatisfactory figures," Health Secretary Rajesh Bhushan said. "We agree that like in any other field, there is a scope for improvement."

India is using a home-grown vaccine developed by Bharat Biotech and the state-run Indian Council of Medical Research, and another licensed from AstraZeneca and Oxford University.

Other vaccines are in the queue, including Russia's Sputnik V and products from Cadila Healthcare, Novavax and Johnson & Johnson.

India, which makes 60 per cent of the world's vaccines, has also exported COVID-19 shots to 24 countries as part of a diplomatic push.